chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: The day following my second dose i had fever; Body aches; Swollen lymph nodes; Fatigue; The night of the day after the vaccine my injection site began to swell and turn red; The night of the day after the vaccine my injection site began to swell and turn red; This is a spontaneous report from a contactable other healthcare professional, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included montelukast sodium (SINGULAIR); taken daily for allergies from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 02Apr2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 08:00, the day following her second dose, she had experienced fever, body aches, swollen lymph nodes and fatigue. On 23Apr2021, the night of the day after the vaccine her injection site began to swell and turned red. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, body aches, swollen lymph nodes, fatigue and the night of the day after the vaccine her injection site began to swell and turn red was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on top of both feet after both shots 1 & 2; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 57-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 21:00, (after both shots 1 and 2), the patient experienced rash on top of both feet. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on top of both feet after both shots 1 and 2 was recovered on an unknown date in Apr2021.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fatigue, Headache, Myalgia
Clinical narrative: Left arm sore and swollen; Left arm sore and swollen; Headache; Fatigue; Sore muscles; Nausea; Fever; Chills; Cold sweats; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 23Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 15:30, the patient experienced left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Left arm sore and swollen; Left arm sore and swollen; Headache; Fatigue; Sore muscles; Nausea; Fever; Chills; Cold sweats; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 23Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 15:30, the patient experienced left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Pain in my right knee not going away; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm  on 09Apr2021 at 09:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 09:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021, the patient experienced pain in right knee which was not going away. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event pain in right knee not going away was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Disease recurrence
Clinical narrative: Had a genital herpes outbreak that started next day. I've only had one previously about 10 years ago.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Apr2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included genital herpes 10 years ago. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had a genital herpes outbreak that started next day on 19Apr2021. The patient only had one previously about 10 years ago. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had a genital herpes outbreak that started next day was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Sluggishness
Clinical narrative: Tired; Sluggish; Fever; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 23Apr2021 at 12:30 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) and venlafaxine hydrochloride (EFFEXOR); both for unknown indication from unknown date and unknown if ongoing. The patient previously received ciprofloxacin (CIPRO) and morphine (MANUFACTURER UNKNOWN); both for unspecified indication from unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 12:30 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. On 24Apr2021 at 10:30, the patient felt tired, sluggish and had fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tired, sluggish, fever was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Disease recurrence, Epistaxis
Clinical narrative: I had some dry blood in my nose in the morning before vaccination as well, but 3 hrs after vaccination, my nose started bleeding; I had some dry blood in my nose in the morning before vaccination as well, but 3 hrs after vaccination, my nose started bleeding; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 24Apr2021 at 01:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included some dry blood in nose in the morning before vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 24Apr2021 at 04:30, 3 hours after vaccination, the patient's nose started bleeding. The patient had some dry blood in nose in the morning before vaccination as well. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had some dry blood in nose in the morning before vaccination as well, but 3 hours after vaccination, nose started bleeding was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokinesia, Muscle spasms
Clinical narrative: Severe cramping in both calf muscles; Cannot sprint, jog, or run; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 03Mar2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 07Mar2021 at 15:00, 4 days after the vaccine the patient suffered severe cramping in both calf muscles while playing basketball. The patient was playing basketball every day and now cannot sprint, jog, or run since March 7th. 24 hours a day, the patient had constant muscle spasms in calves. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with physical therapy with no positive result. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe cramping in both calf muscles and now cannot sprint, jog or run was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Sore at site; Redness at site; Swelling hard tissue at site; Feeling periodic itching at site of injection; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as not applicable). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) for unknown indications, from unknown dates and unknown if ongoing. On 20Apr2021, the patient experienced sore, redness, swelling hard tissue at site and felt periodic itching at site of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events sore, redness, swelling hard tissue at site and felt periodic itching at site of injection were not recovered at the time of report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Paraesthesia, Pruritus, Restless legs syndrome
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 39-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0164), at the age of 39, via an unspecified route of administration, in the left arm, on Apr 23, 2021, at 10:30, single dose, for COVID-19 immunisation. No medical history provided. The patient has no known allergies. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8734), at the age of 39, via an unspecified route of administration, in the left arm, on Apr 2, 2021, at 10:30, single dose, for COVID-19 immunisation. On Apr 23, 2021, at 23:00 (overnight after receiving the second dose of vaccine), patient had restless legs all night. The patient never experienced restless legs previously. All night they felt itchy, tingly and weak when she tried to walk. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The outcome of restless legs all night, felt itchy, tingly and weak when trying to walk resolved on an unknown date in Apr 2021. No follow-up attempts possible. No further information expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Limb discomfort, Musculoskeletal pain, Neck pain
Clinical narrative: Right hand significantly colder than left.; Severe pain in right shoulder blade along bottom curve.; Right arm felt like it weighed a ton; Sore throat; Sore neck; Sore back; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 22Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety. The patient previously received hydrocodone bitartrate/paracetamol (VICODIN) on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); for unknown indications, from an unknown date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021 at 10:30, the patient experienced right hand significantly colder than left, felt like it had been in ice bucket, not painful but very noticeable to the touch. The condition had improved but not resolved. The patient also experienced severe pain in right shoulder blade along bottom curve, which was not improved. The patient's right arm felt like it weighed a ton on 1st day, which was resolved. The patient's joint pain both knees, right hip, right shoulder, both elbows, right wrist was not improved, sore throat, neck and back was not improved, exhaustion was resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm felt like it weighed a ton and exhaustion was recovered on an unknown date in Apr2021. The clinical outcome of the events right hand significantly colder than left was recovering; whereas severe pain in right shoulder blade, joint pain both knees, right hip, right shoulder, both elbows, right wrist and sore throat, neck and back was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Peripheral coldness
Clinical narrative: Right hand significantly colder than left.; Severe pain in right shoulder blade along bottom curve.; Right arm felt like it weighed a ton; Sore throat; Sore neck; Sore back; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 22Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety. The patient previously received hydrocodone bitartrate/paracetamol (VICODIN) on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); for unknown indications, from an unknown date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021 at 10:30, the patient experienced right hand significantly colder than left, felt like it had been in ice bucket, not painful but very noticeable to the touch. The condition had improved but not resolved. The patient also experienced severe pain in right shoulder blade along bottom curve, which was not improved. The patient's right arm felt like it weighed a ton on 1st day, which was resolved. The patient's joint pain both knees, right hip, right shoulder, both elbows, right wrist was not improved, sore throat, neck and back was not improved, exhaustion was resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm felt like it weighed a ton and exhaustion was recovered on an unknown date in Apr2021. The clinical outcome of the events right hand significantly colder than left was recovering; whereas severe pain in right shoulder blade, joint pain both knees, right hip, right shoulder, both elbows, right wrist and sore throat, neck and back was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever; Chills; Nausea; Multiple vomiting incidents; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 21Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN); both for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 20:30, the patient experienced fever, chills, nausea and multiple vomiting incidents. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, nausea and multiple vomiting incidents was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Chronic chest pain. Also sharp stabbing pain from left leg all the way to the chest. Chronic chest pain. Also sharp stabbing pain from left leg all the way to the chest; Dose 1 was on 03Apr2021 and Dose 2 was on 21Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Apr2021 at 01:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 17:30, the patient experienced chronic chest pain and sharp stabbing pain from left leg all the way to the chest. The events resulted in doctor or other healthcare professional office/clinic visit.  Since the vaccination, the patient had been tested for COVID-19. On 19Apr2021, the patient underwent SARS-CoV-2 test (Saliva) and the result was negative. It was unknown if therapeutic measures were taken as a result of the events. The clinical outcome of the events chronic chest pain and sharp stabbing pain from left leg all the way to the chest were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dysphagia, Dyspnoea, Pain in extremity, Paraesthesia
Clinical narrative: About 20 minutes after the vaccination, my arms were tingling; my throat closed up; Trouble swallowing; Trouble breathing; My legs were weak; my arm was sore; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the arm left on 21Apr2021 at 16:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic Lyme disease and sulfonamide allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included imipramine hydrochloride (TOFRANIL) received within two weeks of vaccination. On 21Apr2021 at 17:00, about 20 minutes after the vaccination, the patient experienced her arms were tingling, throat closed up and she had trouble swallowing and breathing. Her legs were weak. Went to the ER and registered, waited an hour and left. By that time her arm was sore, but other symptoms were better. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events arms were tingling, throat closed up, trouble swallowing, trouble breathing, legs were weak and arm was sore were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: About 20 minutes after the vaccination, my arms were tingling; my throat closed up; Trouble swallowing; Trouble breathing; My legs were weak; my arm was sore; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the arm left on 21Apr2021 at 16:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic Lyme disease and sulfonamide allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included imipramine hydrochloride (TOFRANIL) received within two weeks of vaccination. On 21Apr2021 at 17:00, about 20 minutes after the vaccination, the patient experienced her arms were tingling, throat closed up and she had trouble swallowing and breathing. Her legs were weak. Went to the ER and registered, waited an hour and left. By that time her arm was sore, but other symptoms were better. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events arms were tingling, throat closed up, trouble swallowing, trouble breathing, legs were weak and arm was sore were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Pyrexia
Clinical narrative: Fever; Chills; Headache; Loss of energy; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 18Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history (also reported as not applicable). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 23:00, the patient experienced fever, chills, headache and loss of energy. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with TYLENOL from an unknown date. Since the vaccination, the patient had not  been tested for COVID-19. The clinical outcome of the events fever, chills, headache and loss of energy were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea, Pain
Clinical narrative: Felt dizzy; Headache; Felt nauseous; Body ached all over; Fatigued; Got a fever in the middle of the day for an hour or two; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 20Apr2021 at 17:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, sulfonamide allergy, traumatic arthritis, nerve pain, migraine and insomnia. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), suvorexant (BELSOMRA), topiramate (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO); all on an unknown date, for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation.  On 21Apr2021 at 07:00, after 2nd dose, the patient felt dizzy, had a headache, felt nauseous, her body ached all over.  She also got fever in the middle of the day for an hour or two. She was also fatigued. The next day she was still little achy, fatigued and nauseous but was feeling lot better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt dizzy, headache, fever was recovered on an unknown date in Apr2021 whereas, body ached all over, felt nauseous, fatigued was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Felt dizzy; Headache; Felt nauseous; Body ached all over; Fatigued; Got a fever in the middle of the day for an hour or two; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 20Apr2021 at 17:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, sulfonamide allergy, traumatic arthritis, nerve pain, migraine and insomnia. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), suvorexant (BELSOMRA), topiramate (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO); all on an unknown date, for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation.  On 21Apr2021 at 07:00, after 2nd dose, the patient felt dizzy, had a headache, felt nauseous, her body ached all over.  She also got fever in the middle of the day for an hour or two. She was also fatigued. The next day she was still little achy, fatigued and nauseous but was feeling lot better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt dizzy, headache, fever was recovered on an unknown date in Apr2021 whereas, body ached all over, felt nauseous, fatigued was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Rash morbilliform, Rash pruritic, SARS-CoV-2 test
Clinical narrative: Entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. Not painful but mildly itchy; Entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. Not painful but mildly itchy; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 05Apr2021 at 11:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 06Apr2021, the patient experienced entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. It was not painful but mildly itchy. It was reported that it had been 14 days now (at the time of this report) and spread had slowed but was not receding much, only a little bit around neck had gone away. Slightly lighter in color now all over. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events as the patient had been using over the counter 1 percent hydrocortisone creme twice a day for 4 days. On 08Apr2021, the patient underwent PCR test for COVID-19 via nasal swab and the result was negative. The clinical outcome of the events entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. Not painful but mildly itchy was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis, Tinnitus
Clinical narrative: Left ear sounds muffled/ right ear has definite less hearing than left; Right ear mild ringing; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on 23Apr2021 at 14:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to avocados. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 16:00, the patient experienced right ear mild ringing after 2 hours of injection. On 24Apr2021, the left ear sounded muffled like he had water in there. This started when he woke up the morning. The patient tried to get his ear to pop by driving up a high mountain and coming down (12,000 feet elevation) however he could feel it trying to pop but did not. The right ear had definite less hearing than left and was extremely noticeable. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of right ear mild ringing and left ear sounds muffled, right ear has definite less hearing than left was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Decreased appetite, Fatigue, Headache, Pain in extremity
Clinical narrative: Severe body aches in back & legs; Severe body aches in back; Headache; Loss of appetite; Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and allergy to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included medication for birth control (unspecified) and montelukast sodium (SINGULAIR); both from unknown dates, for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 15:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 11:00, the patient experienced severe body aches in back and legs, headache, loss of appetite, fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches in back, severe body aches in legs, headache, loss of appetite, fever and fatigue was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe body aches in back & legs; Severe body aches in back; Headache; Loss of appetite; Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and allergy to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included medication for birth control (unspecified) and montelukast sodium (SINGULAIR); both from unknown dates, for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 15:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 11:00, the patient experienced severe body aches in back and legs, headache, loss of appetite, fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches in back, severe body aches in legs, headache, loss of appetite, fever and fatigue was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Paraesthesia, Pharyngeal swelling
Clinical narrative: Thyroid/throat area swelling; Shortness of breath; Tingling in arms and legs; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Apr2021 at 18:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease, celiac disease and allergies included gluten sensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included thyroid (ARMOUR THYROID) and naloxone hydrochloride, buprenorphine hydrochloride (SUBOXONE) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 16Apr2021, shortness of breath began approximately 24 hours after second dose of vaccine and was continuing up to date. Tingling in arms and legs began approximately 24 hours after vaccine and was continuing to date. On 16Apr2021 at 18:15, 24 hours after vaccine patient experienced thyroid/throat area swelling and was continuing to date. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, tingling in arms and legs and thyroid/throat area swelling was recovering at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Stomatitis
Clinical narrative: Mouth sores; Red bumps all over body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation.  On 23Apr2021, the patient experienced mouth sores and red bumps all over body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mouth sores and red bumps all over body were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.